Theralase Technologies Inc. (TLTFF)
OTCMKTS · Delayed Price · Currency is USD
0.1466
-0.0039 (-2.59%)
Jul 16, 2025, 3:48 PM EDT
Theralase Technologies Revenue
Theralase Technologies had revenue of 91.19K CAD in the quarter ending March 31, 2025, a decrease of -48.06%. This brings the company's revenue in the last twelve months to 949.07K, down -8.63% year-over-year. In the year 2024, Theralase Technologies had annual revenue of 1.03M, down -3.45%.
Revenue (ttm)
949.07K CAD
Revenue Growth
-8.63%
P/S Ratio
56.00
Revenue / Employee
47.45K CAD
Employees
20
Market Cap
36.97M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.03M | -36.88K | -3.45% |
Dec 31, 2023 | 1.07M | -68.26K | -6.00% |
Dec 31, 2022 | 1.14M | 357.93K | 45.85% |
Dec 31, 2021 | 780.64K | -148.48K | -15.98% |
Dec 31, 2020 | 929.12K | -34.93K | -3.62% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Theralase Technologies News
- 19 days ago - Theralase(R) Extends Warrants - Newsfile Corp
- 4 weeks ago - Theralase(R) Closes Non-Brokered Private Placement - Newsfile Corp
- 4 weeks ago - Theralase Completes Annual General and Special Meeting - Newsfile Corp
- 5 weeks ago - Theralase Technologies Inc. (TLTFF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Theralase Annual General Meeting - Newsfile Corp
- 6 weeks ago - Theralase(R) 1Q2025 Financial Statements - Newsfile Corp
- 6 weeks ago - CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025 - Newsfile Corp
- 7 weeks ago - Theralase to Present Groundbreaking Research at ASTRO 2025 - Newsfile Corp